Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ketamine by NRX Pharmaceuticals for Bipolar Disorder (Manic Depression): Likelihood of Approval
Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression). According to...
Data Insights
Ketamine by Seelos Therapeutics for Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy): Likelihood of Approval
Ketamine is under clinical development by Seelos Therapeutics and currently in Phase I for Complex Regional Pain Syndrome (Sympathetic Reflex...